Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3&bgr;

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|10|1|90-97

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.10, Iss.1, 2014-02, pp. : 90-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite

CDK9 a Potential Target for Drug Development

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2883-2890

Bentham Science Publishers

Access to resources Recommend Favorite

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3361-3369

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 3, 2003-09 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite